USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
THIRD WAVE TECHNOLOGIES, INC.
Address:
THIRD WAVE TECHNOLOGIES, INC.
506 S ROSA RD
MADISON, WI 53719
Phone:
(608) 273-8933
URL:
N/A
EIN:
391791034
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $982,826.00 14
SBIR Phase II $3,626,664.00 6

Award List:

A High Throughput Automated DNA Sequencer

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$49,200.00
Agency:
HHS
Principal Investigator:
Lance Fors
Abstract:
N/a

Universal System for Directed Nucleic Acid Cleavage

Award Year / Program / Phase:
1994 / SBIR / Phase I
Award Amount:
$75,000.00
Agency:
HHS
Principal Investigator:
Maryann Brow
Abstract:
We will develop a novel system for directed nucleic acid cleavage. This system is based uponour discovery that the 5' nucleases of several thermostable DNA polymerases can be directed to cleaveas site-specific endonucleases. This system will be thermostable, specific, efficient and… More

SIGNAL AMPLIFICATION FOR SPECIFIC NUCLEIC ACID DETECTION

Award Year / Program / Phase:
1994 / SBIR / Phase I
Award Amount:
$75,000.00
Agency:
DOE
Principal Investigator:
Ms Mary Ann D Brow
Abstract:
N/a

A High Throughput Automated DNA Sequencer

Award Year / Program / Phase:
1995 / SBIR / Phase II
Award Amount:
$497,240.00
Agency:
HHS
Principal Investigator:
Lance Fors
Abstract:
We will commercialize a high-speed instrument for automated DNA sequence analysis. Such an instrument is essential to the success of the Human Genome Initiative; the sequence of the human genome will be determined and used as a powerful tool for biological and medical research. Two key aspects of… More

SIGNAL AMPLIFICATION FOR SPECIFIC NUCLEIC ACID DETECTION

Award Year / Program / Phase:
1995 / SBIR / Phase II
Award Amount:
$750,000.00
Agency:
DOE
Principal Investigator:
Ms Mary Ann D Brow
Abstract:
This project will attempt to commercialize a novel, high-speed, and automatable dna and rna diagnostic technology for the specific detection of nucleic acid sequence changes associated with genetic diseases. this technology is based on the discovery that the 5' nuclease of several thermostable dna… More

QUANTITATIVE THERMOSTABLE EXONUCLEASE DETECTION ASSAY

Award Year / Program / Phase:
1996 / SBIR / Phase I
Award Amount:
$97,897.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

DETECTION OF RIFAMPIN RESISTANT M TUBERCULOSIS

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$85,308.00
Agency:
HHS
Principal Investigator:
Neri, bruce p
Abstract:
N/a

Cflp based determination of hepatitis C virus genotype

Award Year / Program / Phase:
1997 / SBIR / Phase II
Award Amount:
$600,888.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

NEW METHOD FOR DIRECT AND QUANTITATIVE RNA DETECTION

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Brow, Mary A
Abstract:
N/a

LOW COST HIV DRUG SUSCEPTIBILITY PROFILING

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Kwiatkowski, Robert W
Abstract:
N/a

SPECIFIC AND SENSITIVE MUTATION AND SNP DETECTION

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$100,421.00
Agency:
HHS
Principal Investigator:
Bruce P. Neri
Abstract:
Not Available Effective use of large area SIC thyristors has been limited by the decreasing breakdown strength as the size of device increases. The proposed project aims to develop a cost-effective method to greatly improve the breakdown voltage of devices and minimize the dependence of their… More

LOW COST HBV DRUG SUSCEPTIBILITY PROFILING

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Robert W. Kwiatkowski
Abstract:
Not Available Dynetics, Incorporated proposes to design (Phase I) and develop (Phase I and Phase II) an infrastructure within which the Air Force Research Lab Munitions Directorate can integrate software modules for vulnerability and lethality assessment. The objective of this effort is to address… More

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Hon S. Ip
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$393,659.00
Agency:
HHS
Principal Investigator:
Hon S. Ip
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Robert W. Kwiatkowski
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$276,251.00
Agency:
HHS
Principal Investigator:
Robert W. Kwiatkowski
Abstract:
N/a

Genetic Profiles for Perioperative Applications

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Robert W. Kwiatkowski
Abstract:
The goal of this project over Phase I is to create and test the analytical validity of novel Invader mutation detection assays designed for applications specific to surgery and anesthesia. Invader technology, based on a highly specific enzyme-substrate reaction, enables direct analysis of genomic… More

A HTS GENE EXPRESSION ASSAY FOR SCREENING NUTRACEUTICALS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
The goal of this project is to create a high throughput, sensitive, quantitative and cost-effective platform for measuring gene expression in response to natural compounds derived from foods -nutraceuticals. This technology, the RNA InvaderTM assay, offers highly sensitive detection of mRNA… More

Genetic Profiles for Perioperative Applications

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The objectives of Phase II are to develop, validate, and commercialize a tool for detecting genotypes affecting patient care and safety during the perioperative interval (before, during, and immediately following surgery). Despite publications describing genetic… More

Genetic Profiles for Perioperative Applications

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$1,108,626.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The objectives of Phase II are to develop, validate, and commercialize a tool for detecting genotypes affecting patient care and safety during the perioperative interval (before, during, and immediately following surgery). Despite publications describing genetic… More